These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 5076528

  • 41. [Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
    Lenaerts A, Codden T, Henry JP, Van Cauter J, Meunier JC, Ligny G.
    Gastroenterol Clin Biol; 2001 Mar; 25(3):268-72. PubMed ID: 11395674
    [Abstract] [Full Text] [Related]

  • 42. [Effect of spironolactone and K-canrenoate in ascitic cirrhosis. Double-blind study].
    Tempini S, Bellati G, Ideo G.
    Minerva Dietol Gastroenterol; 1984 Mar; 30(3):255-61. PubMed ID: 6504374
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. [1st results of the use of Soludactone in the treatment of certain forms of cerebral edema].
    Ravon R, Imbert D, Guibert B, Fischer G, Mansuy L.
    J Med Lyon; 1970 Apr 05; 51(184):885-92. PubMed ID: 5476420
    [No Abstract] [Full Text] [Related]

  • 45. [Anti-aldosterone therapy in cirrhosis of the liver with ascites].
    Loginov AS, Berezov VM.
    Sov Med; 1967 Feb 05; 30(2):39-42. PubMed ID: 5597952
    [No Abstract] [Full Text] [Related]

  • 46. Management of primary and secondary hyperaldosteronism.
    Br Med J; 1969 Aug 23; 3(5668):427-8. PubMed ID: 5811648
    [No Abstract] [Full Text] [Related]

  • 47. [Treatment of hyperaldosteronism].
    Jacobelli A.
    Clin Ter; 1984 Jun 30; 109(6):575-81. PubMed ID: 6236949
    [No Abstract] [Full Text] [Related]

  • 48. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?].
    Brilla CG, Schencking M, Scheer C, Rupp H.
    Praxis (Bern 1994); 1997 Apr 02; 86(14):566-74. PubMed ID: 9198851
    [Abstract] [Full Text] [Related]

  • 49. Spironolactone for heart failure.
    Med Lett Drugs Ther; 1999 Sep 10; 41(1061):81-2. PubMed ID: 10505071
    [No Abstract] [Full Text] [Related]

  • 50. Overlapping spironolactone dosing in primary aldosteronism and resistant essential hypertension.
    Handler J.
    J Clin Hypertens (Greenwich); 2012 Oct 10; 14(10):732-4. PubMed ID: 23031155
    [No Abstract] [Full Text] [Related]

  • 51. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M, Takada M, Hirooka K, Isobe F, Yasumura Y.
    J Clin Pharm Ther; 2005 Dec 10; 30(6):603-10. PubMed ID: 16336294
    [Abstract] [Full Text] [Related]

  • 52. [Spironolactone in digitalis-requiring cardiac insufficiency following pacemaker implantation].
    Sabin G, Klüsener W.
    Med Klin; 1981 Jan 02; 76(1):20-3. PubMed ID: 7254119
    [Abstract] [Full Text] [Related]

  • 53. The effect of spironolactone use on heart failure mortality: a population-based study.
    Ouzounian M, Hassan A, Cox JL, Johnstone DE, Howlett J, Improving Cardiovascular Outcomes in Nova Scotia Study Investigators.
    J Card Fail; 2007 Apr 02; 13(3):165-9. PubMed ID: 17448412
    [Abstract] [Full Text] [Related]

  • 54. The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure.
    Shah KB, Rao K, Sawyer R, Gottlieb SS.
    J Am Coll Cardiol; 2005 Sep 06; 46(5):845-9. PubMed ID: 16139135
    [Abstract] [Full Text] [Related]

  • 55. Diuretics in the treatment of patients who present congestive heart failure and hypertension.
    Reyes AJ.
    J Hum Hypertens; 2002 Mar 06; 16 Suppl 1():S104-13. PubMed ID: 11986906
    [Abstract] [Full Text] [Related]

  • 56. Does the amount of edema in patients affect the magnitude of response to a dose of a diuretic acting on the renal tubules?
    Gold H, Messeloff CR, Mehta D, Kwit NT, Golfinos AJ, Zahm WN, Goessel E, Morris A.
    J Clin Pharmacol J New Drugs; 1969 Mar 06; 9(6):374-83. PubMed ID: 5260200
    [No Abstract] [Full Text] [Related]

  • 57. [Chronic heart insufficiency should be treated also with spironolactone].
    Kjeldsen KP, Nørgaard A, Thygesen K.
    Ugeskr Laeger; 1999 Sep 13; 161(37):5132. PubMed ID: 10523942
    [No Abstract] [Full Text] [Related]

  • 58. Good blood pressure control on antihypertensives, not only response to spironolactone, predicts improved outcome after adrenalectomy for aldosteronoma.
    Zarnegar R, Lee J, Brunaud L, Lindsay S, Kebebew E, Clark OH, Duh QY.
    Surgery; 2007 Dec 13; 142(6):921-9; discussion 921-9. PubMed ID: 18063077
    [Abstract] [Full Text] [Related]

  • 59. Bilateral adrenal cortical hyperplasia.
    Slifer A, Aronoff DM.
    Tenn Med; 2000 May 13; 93(5):172-3. PubMed ID: 10821072
    [No Abstract] [Full Text] [Related]

  • 60. [Clinical evaluation of bumetanide in the diuretic treatment of heart failure and liver cirrhosis].
    Mauro G, Cantino G, Vigiani L.
    Clin Ter; 1981 Mar 15; 96(5):515-21. PubMed ID: 7285521
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.